-
GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients
15 Jul 2025 12:14 GMT
… the US Food and Drug Administration (FDA) to extend use … on a Phase IIIb trial (NCT06389487) that produced … on going forward, with infectious disease experts concerned about the … our leading industry insights.
Pharmaceutical Technology Excellence Awards - …
-
ViiV Healthcare data show 89% of treatment-naïve people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily pills after achieving rapid viral suppression
15 Jul 2025 09:24 GMT
… not having to carry medication (68%). These findings … with daily oral pills, offering improved treatment satisfaction, high … clinics primary care and infectious disease clinics in the US. … transcriptase inhibitor (NNRTI) developed by Janssen Sciences Ireland …
-
Olorofim Phase IIb trial shows efficacy in invasive fungal disease for patients with limited treatment options
15 Jul 2025 08:53 GMT
… drug resistance spreads and conventional treatments … Infectious Diseases, researchers evaluated the efficacy, safety, tolerability, and pharmacokinetics … Infectious Diseases … trial shows efficacy in invasive fungal disease for patients with limited treatment …
-
2 pharmacies deny COVID-19 vaccine to immunocompromised Vero Beach man
15 Jul 2025 08:17 GMT
… Public Health Association, the Infectious Diseases Society of America, the … when two Treasure Coast pharmacies refused to vaccinate him, … but like Publix, the pharmacy did not answer TCPalm… a second prescribed immunosuppressant drug in March.
Then his …
-
Syringe Programs Boost Hepatitis C Treatment for People Who Inject Drugs
15 Jul 2025 08:07 GMT
… Infectious Diseases, researchers warn that a lack of sustainable funding and limited treatment … intervention. Sharing equipment for injection drug use is a major risk … their antiviral drugs on site or from a specified pharmacy or having …
-
60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025
14 Jul 2025 20:01 GMT
… of tafenoquine to treat acute canine babesiosis … Drug Interactions Avoid co-administration with drugs that … developing and marketing new medicines for the treatment and prevention of infectious diseases … 60 Degrees Pharmaceuticals, Inc. achieved FDA approval of …
-
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
14 Jul 2025 13:30 GMT
… system by streamlining early-stage drug discovery, reducing wet lab dependency … developments from Tevogen.AI’s platforms, including advancements in clinical trial … its product candidates for the treatment of infectious diseases and cancer. Forward-looking …
-
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
14 Jul 2025 12:30 GMT
… NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq … infectious diseases and gastroenterology (GI) oncology indications. In addition to advancing the development … and Drug Administration (FDA), … drug candidates for patients with cancer in need of new treatment …
-
Catch a Fraudulent Scientist If You Can
15 Jul 2025 11:42 GMT
… to help develop its pioneering treatment in matrix- … for studying and treating diseases involving tissue- … include cancer, neurodegenerative and infectious diseases, cardiovascular, and metabolic … A researcher falsifying clinical trial data could, for example …
-
A Group of Antimicrobial Compounds Show Novelty Action Against Multidrug-Resistant Gonorrhea
15 Jul 2025 11:48 GMT
… Infectious Diseases. This grant allows the company to further advance research and development … to treat multidrug-resistant bacterial infections. Their investigational drug candidates … early stages of development and TAXIS Pharmaceuticals Chief Scientific …
About
© 1995-2025